AS FILED WITH THE SECURITIES AND EXCHANGE
COMMISSION ON JULY 31, 2001.
Registration No. 333-59494
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 2
TO FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
----------
Intelli-Check, Inc.
(Exact name of registrant as specified in its charter)
DELAWARE 113234779
(State or other jurisdiction of (I.R.S. Employee
incorporation or organization Identification Number)
246 Crossways Park West
Woodbury, New York 11797
(516) 992-1900
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Frank Mandelbaum
Chairman and Chief Executive Officer
Intelli-Check, Inc.
246 Crossways Park West
Woodbury, New York 11797
(Name, address, including zip code, and telephone number, including
area code, of agent for service)
Copies to: Arnold Bressler, Esq.
Milberg Weiss Bershad Hynes & Lerach, LLP
One Pennsylvania Plaza
New York, New York 10119-0165
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: From time to
time after this Registration Statement becomes effective.
If the only securities being registered on this Form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. |_|
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933 (as defined below), other than securities offered only in connection with
dividend or interest reinvestment plans, check the following box. |X|
If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. |_|
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |_|
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. |_|
CALCULATION OF REGISTRATION FEE
================================================================================
========================
TITLE OF EACH CLASS MAXIMUM PROPOSED MAXIMUM
OF SECURITIES TO BE AMOUNT TO BE OFFERING PRICE AGGREGATE OFFERING
AMOUNT OF
REGISTERED REGISTERED PER SHARE (1) PRICE (1)
REGISTRATION FEE (5)
--------------------------------------------------------------------------------
------------------------
Common Stock $.001
par value per share 970,076(3) $8.50(2)(4) $8,245,646(2)(4)
$2,061.41(2)
================================================================================
========================
(1) Calculated pursuant to Rule 457 under the Securities Act of 1933.
(2) Dividend distribution to holders of Common Stock.
(3) Reflects up to 970,076 shares of Common Stock issuable upon exercise of
Common Stock Purchase Rights (the "Rights") that will be issued by the
Company as a dividend to its Common Stockholders of record on March 30,
2001. The Rights will be distributed as soon as practicable after the
effective date of this Registration Statement. Rights will also attach to
shares of Common Stock underlying vested stock options and warrants
outstanding on March 30, 2001. These Rights will be issued upon exercise
of such options and warrants.
(4) Based upon the $8.50 per share exercise price of the Rights.
(5) Previously paid.
The Registrant hereby amends this Registration Statement on such date or dates
as may be necessary to delay its effective date until the Registrant shall file
a further amendment which specifically states that this Registration Statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act or until this Registration Statement shall become effective on
such date as the Securities and Exchange Commission, Acting Pursuant to said
Section 8(a), may determine.
================================================================================
-2-
SUBJECT TO COMPLETION - DATED JULY , 2001
================================================================================
PROSPECTUS
______________, 2001
Intelli-Check, Inc.
970,076 Shares of Common Stock
================================================================================
Our Board of Directors declared a dividend of rights to purchase our
common stock to holders of record as of March 30, 2001. Through this prospectus,
we are offering the shares of common stock that rightsholders may purchase upon
exercising the rights. These rights cannot be transferred.
- You will receive one right for each ten shares of our common stock which
you own on the record date of March 30, 2001. For each right which you
exercise, you will be able to purchase one share of our common stock at a
price of $8.50.
- We will not issue fractional rights or fractional shares, and we will not
pay cash in place of rights or fractional shares.
- The rights are non-transferrable and holders who want to exercise must
certify that they have held the common stock to which the rights attach
continuously from March 30, 2001 through the exercise date.
- The rights are exercisable beginning on the date of this prospectus and
continuing until 5:00 p.m. Eastern Standard Time on ___________, 2002, the
expiration date. If you want to participate in this rights dividend, you
must submit your subscription documents to us before the expiration date,
in the manner described in this prospectus. The duration of the offering
of the common stock underlying the rights will be for one year beginning
on the date the registration statement of which this prospectus is a part
is declared effective. We anticipate that the latest date reasonably
expected for the termination of this offering is December 2002.
- The rights are redeemable at our option, upon 30 days' notice at a
redemption price of $0.01 per right, if the last sale price for our common
stock exceeds $10.50 for 20 consecutive trading days or upon a change of
control.
- There is no minimum number of shares that must be sold and all proceeds,
if any, less expenses, received from the exercise of the rights will be
retained by us.
Offering Price: $8.50
Our common stock is quoted on the American Stock Exchange under the symbol
"IDN."
----------
This investment involves risk. See "Risk Factors" beginning on page 5 for
a discussion of certain material factors that you should consider in connection
with an investment in our common stock.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a
criminal offense.
-3-
No dealer, salesperson or other person has been authorized to give any
information or to represent anything not contained in the prospectus. You may
not rely on any unauthorized information or representations. We may not sell
these securities until the date of this prospectus. The prospectus is not an
offer to sell these securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not permitted.
================================================================================
TABLE OF CONTENTS
Page
Risk Factors .............................................................. 5
Use of Proceeds ........................................................... 7
Determination of Offering Price ........................................... 7
Shares Underlying Warrants and Options Eligible to Receive Rights ......... 7
Plan of Distribution ...................................................... 8
Description of Rights ..................................................... 8
Certain Federal Income Tax Considerations ................................. 13
Legal Matters ............................................................. 17
Experts ................................................................... 17
Principal Office .......................................................... 17
Material Changes .......................................................... 17
Where You Can Find More Information ....................................... 17
Incorporation of Certain Documents by Reference ........................... 17
================================================================================
-4-
This prospectus contains forward-looking statements based on our current
expectations, assumptions, estimates and projections about our Company and our
industry. Our actual results could differ materially from those anticipated in
these forward-looking statements as a result of various factors, including all
the risks discussed in "Risk Factors" and elsewhere in this prospectus. We do
not undertake to update publicly any forward-looking statements for any reason,
even if new information becomes available or other events occur in the future.
RISK FACTORS
You should carefully consider the following factors and other information.
The risks and uncertainties described below are not the only ones facing us.
Additional risks and uncertainties may also adversely impair our business
operations. If any of the following risks actually occur, our business,
financial condition or results of operations could be materially and adversely
affected.
Because we have experienced losses and expect our expenses to increase, we may
not be able to achieve profitability.
We have incurred operating losses since our inception. We had an
accumulated deficit of $6,936,011 at December 31, 2000. We cannot assure you
that our revenues will become significant or that we will ever achieve
profitable operations.
If we are unable to obtain additional financing when needed, we will be required
to curtail our marketing and production plans and possibly cease operations.
Our capital requirements have been and will continue to be significant.
Not including any proceeds from this offering, we currently anticipate that our
available cash resources and expected revenues combined with the $958,800 we
expect to receive from the exercise of the expiring warrants by our
warrantholders before expiration will be sufficient to meet our anticipated
working capital and capital expenditure requirements of $4,400,000 for fiscal
year 2001 through December 31, 2001. If we fail to attain significant sales or a
positive cash flow, we may be required to reduce certain costs or seek
additional equity or debt financing to fund the costs of our operations. We
cannot assure you that additional financing will be available to us when needed,
on commercially reasonable terms, or at all.
A third party is seeking to invalidate our patent which could cause the
development and marketing of products which will directly compete with ours.
The IdentiScan Company, LLC offers a product that electronically reads and
calculates age from a driver license. Although we had informed IdentiScan that
we believed its product infringed on our patent, we had not initiated a legal
claim against them; however, in August 1999, IdentiScan filed a complaint
against us in Connecticut which
-5-
seeks to have the IdentiScan product declared non-infringing on our patent and
seeks to have our patent declared invalid. The complaint does not state the
basis for the action nor does it seek monetary damages. We believe that our
patent, to which we hold clear title, is valid and fully enforceable, and we are
vigorously defending it. We also believe IdentiScan's claim of non-infringement
is without merit. In late 1999, in response to our motion to dismiss for lack of
jurisdiction, IdentiScan withdrew its suit against us in Connecticut and
re-filed it in Delaware where it is presently in the discovery stage. If our
patent were to be declared invalid or if our patent were to be otherwise
limited, we believe it would have an adverse effect on our business and future
success because other companies, including IdentiScan, might be able to use some
or all of the technology covered by our patent to develop and market products
which will directly compete with our products. Furthermore, if we were required
to devote a significant portion of our funds to defend our patent, we would have
less money available for other purposes.
We currently rely on one hardware supplier to provide us with the terminals we
need to run our ID-Check software. Delays and inconsistencies in the quality of
the terminals could result in lost sales.
Welch Allyn, Inc. supplies us with our hardware terminals, which run our
patented software. If Welch Allyn does not meet our delivery requirements, we
may have to seek an alternate supplier. While we believe alternate suppliers
would be available, any delay in securing a new source on satisfactory terms or
within the time frame to meet our sales goals could have a material adverse
effect on our marketing plans. Since we will not have direct control over the
manufacturing process, the possibility of delays and inconsistencies in quality
could result in the failure to fulfill sales orders and the cancellation of
potential orders, which could damage our reputation.
If governmental agencies were to stop sharing data with us, our business would
be damaged.
Currently, a number of states and Canadian provinces which conform to the
guidelines established by standardization bodies cooperate with us by providing
sample driver licenses and identification cards so that we may program the
ID-Check terminal to read and analyze the encoded information found on the
driver licences and identification cards. We cannot assure you that these
jurisdictions will continue to cooperate with us.
Future government regulation restricting access to information electronically
stored on driver licenses could adversely affect our business.
Our products can be used to capture information from driver licenses.
Currently, our customers are not legally restricted from using this information
for their own use. Because issues of personal privacy are currently a major
topic of public policy debate, it is possible that in the future merchants may
be restricted from capturing this information. In that event, we could
anticipate an adverse effect on our business.
If we fail to conform to emerging technological standards, our products could
become outdated and less attractive to potential customers.
Our success depends upon our ability to maintain and develop competitive
technologies to continue to enhance our products and to conform to emerging
technological standards in a timely and cost-effective manner. Developing these
products may require substantial time and expense. We
-6-
cannot assure you that we will be able to respond quickly, cost-effectively or
sufficiently to developments affecting our market. Our business, financial
condition and operating results may be adversely affected if we are unable to
anticipate or respond quickly to any developments.
There is no minimum number of shares being offered, therefore our expenses could
exceed our proceeds.
Because there is no minimum number of shares being offered, we may not
receive enough proceeds to cover our estimated expenses of $87,000 for this
offering. If this occurs, the book value of our company may be lower after the
expiration of this offering.
USE OF PROCEEDS
The estimated expenses of this offering are $87,000 and the range of net
offering proceeds is zero if no holders exercise their rights and $8,158,646 if
all warrant holders exercise their warrants and then their rights, all option
holders exercise their options and their rights and all present common stock
holders exercise their rights.
We will use the net proceeds, if any, realized from the exercise of the
rights for working capital and for general corporate purposes, at the discretion
of our management.
DETERMINATION OF OFFERING PRICE
The offering price of the shares offered upon exercise of the rights is
$8.50 per share and was determined without regard to the market price of our
common stock, the prevailing market conditions, our operating results in recent
periods, our book value or other recognized criteria of value nor was the
offering price considered in relation to the exercise prices of outstanding
warrants and options.
SHARES UNDERLYING WARRANTS AND OPTIONS ELIGIBLE TO RECEIVE RIGHTS
The table below sets forth information on the warrants and options
outstanding which, once exercised to purchase common stock, would entitle the
holder to exercise the rights:
Type Quantity Exercise Price Number of Rights Eligible
---- -------- -------------- -------------------------
Warrants 353,350 $ 3.00 35,335
Warrants 10,000 8.40 1,000
Options 1,064,000 3.00 106,400
50,000 5.00 5,000
99,000 7.50 9,900
5,000 8.00 500
161,480 $8.25 - $8.75 16,148
10,000 9.00 1,000
1,000 9.38 100
2,000 9.50 200
3,599 10.06 360
1,000 10.63 100
25,000 11.00 2,500
15,000 11.31 1,500
50,000 11.63 5,000
18,000 12.13 1,800
4,410 13.25 441
--------- -------
Total 1,872,839 187,284
========= =======
-7-
PLAN OF DISTRIBUTION
The rights entitle the holders to acquire up to approximately 970,076
shares of common stock on a fully diluted basis assuming all rights are
exercised upon payment of the applicable exercise price. We issued the rights as
a dividend to all of our stockholders of record on March 30, 2001. Rights also
attached to shares of common stock underlying all vested stock options and
warrants outstanding on March 30, 2001.
We are offering the shares of common stock underlying the rights. No
underwriter or placement agent has been engaged to assist us in this regard and
no commissions or similar compensation will be paid to any person. The shares of
common stock to be issued upon exercise of the rights are offered on a delayed
or continuous basis pursuant to Rule 415 under the Securities Act. Our transfer
agent, Continental Stock Transfer & Trust Company is acting as our rights agent
to effect the exercise of the rights and the issuance of the underlying common
stock. Thus, we anticipate that our officers' and employees' role will be
limited to:
o responding to inquiries of a potential purchaser provided the
response is limited to information contained in the registration statement of
which this prospectus is a part and
o ministerial and clerical work involved in effecting transactions
pertaining to the sale of the common stock underlying the rights.
DESCRIPTION OF RIGHTS
GENERAL
The shares of common stock being offered are issuable to you upon the
exercise of the rights. Stockholders of record on March 30, 2001 will receive a
dividend of one right for every ten (10) shares of common stock that they hold.
The rights will be distributed as soon as practicable after the date of this
prospectus. Each Right will entitle the holder to purchase one share of common
stock at an exercise price of $8.50. The rights are exercisable for a one-year
period beginning on the date of this prospectus. The one-year duration runs from
the date the registration statement pertaining to the underlying common stock is
declared effective. Because we do not know when the registration statement will
be declared effective, we cannot definitively state when we expect the offering
to be terminated, but we would anticipate that the latest date reasonably
expected for termination of this offering is December 2002. Holders who wish to
exercise their rights must certify that they have held the common stock to which
the rights attach continuously from March 30, 2001 through the exercise date.
Holders of vested stock options and holders of outstanding warrants to
purchase common stock as of March 30, 2001 also will be entitled to receive
rights based on the number of shares of common stock underlying the vested stock
options or warrants held on the respective record dates. One right will attach
to every ten (10) shares of common stock underlying vested stock options and
warrants held of record on March 30, 2001. The number of rights relating to the
amount of common
-8-
stock purchased upon exercise of vested stock options or warrants will be issued
to the vested stock option holders or warrant holders upon exercise of the
vested stock options or warrants.
Beneficial owners of common stock who are not record holders should
contact the nominee rightsholder to obtain a separate rights certificate. See "
-- Exercise of Rights."
NON-TRANSFERABLE
The rights are not transferable and bear a legend to that effect and may
only be exercised by the original holder.
EXPIRATION
In the event the rights are not exercised within the applicable one-year
period, all unexercised rights will expire and will no longer be exercisable. We
may extend the rights exercise period if authorized by our Board of Directors
and will give thirty (30) days' notice to the rightsholders. The rights will
expire and become unexerciseable upon conclusion of the applicable exercise
period, or any extension.
REDEMPTION
The rights are redeemable at our option, upon 30 days' notice at a
redemption price of $0.01 per right, if the last sale price for our common stock
exceeds $10.50 for 20 consecutive trading days or upon a change of control. The
exercise price, number and kind of shares to be received upon exercise of the
rights are subject to adjustment, in the discretion of our Board of Directors,
on the occurrence of certain events, such as stock splits, stock dividends or a
recapitalization. If there is a liquidation, dissolution or winding up of our
company, the rightsholders will not be entitled to participate in the
distribution of our assets. Additionally, rightsholders have no voting,
pre-emptive, liquidation or other rights of stockholders, and no dividends will
be declared on the rights or the shares underlying the rights.
A change of control means any event where:
o any person or group is or becomes the beneficial owner of shares
representing more than 50% of the combined voting power of the
then-outstanding securities entitled to vote generally in elections
of directors.
o we consolidate with or merge into any other corporation, or any
other corporation merges into us, and, our outstanding common stock
is reclassified into or exchanged for any other property or
security, unless our stockholders immediately before such
transaction own, directly or indirectly immediately following such
transaction, at least a majority of the combined voting power of the
outstanding voting securities of the corporation resulting from such
transaction in substantially the same proportion as their ownership
immediately before such transaction.
o we convey, transfer or lease all or substantially all of our assets
to any corporation (or other entity).
-9-
EXERCISE OF RIGHTS
The rights may be exercised only to the extent that beneficial ownership
of some or all of the shares to which the rights relate have been continuously
held from March 30, 2001 or the date on which a holder of a vested option or
warrant exercises through the date of exercise of the rights. Any transfers of
beneficial ownership of shares between March 30, 2001 or the vested
option/warrant exercise date, will correspondingly reduce the number of rights,
that may be exercised. To illustrate:
o A rightsholder who beneficially owns 100 shares on March 30, 2001
will receive ten (10) rights (based on the 1:10 ratio of rights to
shares held).
o If, between March 30, 2001 and the date of exercise of the rights,
the rightsholder transfers beneficial ownership of 20 out of the 100
shares, then the rightsholder may only exercise eight of the rights.
o If, between March 30, 2001 and the date of exercise of the rights,
the rightsholder instead transfers beneficial ownership of 11 out of
the 100 shares, then the rightsholder still may only exercise eight
of the rights because fractional rights are rounded down to the
nearest whole right.
A rightsholder who is both the record holder and beneficial owner of the
shares of common stock to which the rights relate must certify as to the number
of shares beneficially owned on March 30, 2001 or the vested option/warrant
exercise date, as applicable. The rightsholder must also certify as to the
number of shares that, as of the date of exercise, continue to be beneficially
owned, having not been transferred since March 30, 2001 or the vested
option/warrant exercise date, as applicable.
A rightsholder who holds shares of common stock for the account of others,
such as a broker, a trustee or a depository for securities must certify as to
the number of shares beneficially owned on March 30, 2001 or the vested
option/warrant exercise date, as applicable, by each beneficial owner for which
the rightsholder holds shares. Rightsholders must also certify as to the
corresponding number of shares that, as of the date of exercise, continue to be
beneficially owned, having not been transferred since March 30, 2001 or the
vested option/warrant exercise date, as applicable.
We intend to monitor beneficial ownership by rightholders who elect to
exercise all or a portion of their rights.
Rights may be exercised by delivering to Continental Stock Transfer &
Trust Company, the rights agent, on or prior to 5:00 p.m., New York time, on the
expiration date, the properly completed
-10-
and executed rights certificate evidencing the rights with any required
signature guarantees, together with payment in full of the exercise price for
each right exercised. The payment in full must be by:
o check drawn upon a U.S. bank or postal, telegraphic or express money
order payable to Continental Stock Transfer & Trust Company as agent
for Intelli-Check, Inc.; or
o wire transfer of funds to the account maintained by the rights agent
for this purpose. For the rights agent's wire transfer information,
please call (212) 509-4000 extension 535.
Payment of the exercise price will be deemed to have been received by the rights
agent only upon
o clearance of any uncertified check,
o receipt by the rights agent of any certified check drawn upon a
United States bank or of any postal, telegraphic or express money
order, or
o receipt of good funds in the rights agent's account designated
above.
If paying by uncertified personal check, please note that it may take at
least five business days to clear. Accordingly, holders who wish to pay the
exercise price by means of an uncertified personal check are urged to make
payment sufficiently in advance of the expiration date to ensure that their
payment is received and clears by the expiration date and are urged to consider
payment by means of certified or cashier's check, money order or wire transfer
of funds.
If a rightsholder wishes to exercise rights, but time will not permit the
rightsholder to cause the rights certificate or rights certificates evidencing
the rights to reach the rights agent on or prior to the expiration date, the
rights may still be exercised if all of the following conditions are met:
o the rightsholder has made payment of the exercise price for each
share of common stock being subscribed for and the rights agent
receives this payment on or prior to the expiration date;
o the rights agent receives, on or prior to the expiration date, a
guaranteed notice in the form distributed with the rights
certificates, from a member firm of a registered national securities
exchange or a member of the National Association of Securities
Dealers, Inc., or from a commercial bank or trust company having an
office or correspondent in the United States, stating:
o the name of the exercising rightsholder,
o the number of rights represented by the rights certificate(s)
held by the exercising rightsholder,
o the number of shares of common stock being purchased and
guaranteeing the delivery to the rights agent of any rights
certificate(s) evidencing the rights within three American
Stock Exchange trading days following the date of the
guaranteed notice; and
-11-
o the properly completed rights certificate(s), with any required
signatures guaranteed, is received by the rights agent within three
American Stock Exchange trading days following the date of the
guaranteed notice. The guaranteed notice may be delivered to the
rights agent in the same manner as rights certificates at the
addresses set forth above, or may be transmitted to the rights agent
by facsimile transmission (telecopy no. (212) 616-7610). Additional
copies of the form of guaranteed notice are available upon request
from the rights agent, whose address and telephone numbers are set
forth below.
A rightsholder who holds shares of common stock for the account of others,
such as a broker, a trustee or a depository for securities, should notify the
respective beneficial owners of such shares as soon as possible to ascertain
such beneficial owner's intentions and to obtain instructions with respect to
the rights. If the beneficial owner so instructs, the record holder of such
rights should complete the rights certificate and submit it to the rights agent
with the proper payment. In addition, the beneficial owner of common stock or
rights held through such a holder of record should contact the rightsholder and
request the rightsholder to effect transactions in accordance with the
beneficial owner's instructions.
Unless a rights certificate provides that the shares of common stock to be
issued pursuant to the exercise of rights are to be delivered to the
rightsholder or is submitted for the account of an institution, signatures on
such rights certificate must be guaranteed by an eligible institution.
If either the number of shares being subscribed for is not specified on
the rights certificate, or the amount delivered is not enough to pay the
exercise price for all shares stated to be purchased, the number of shares
purchased will be assumed to be the maximum amount that could be purchased upon
payment of such amount, after allowance for the exercise price of any specified
shares.
DO NOT SEND RIGHTS CERTIFICATES TO INTELLI-CHECK.
The method of delivery of rights certificates and payment of the exercise
price to the rights agent will be at the election and risk of the rightsholder,
but if sent by mail it is recommended that such certificates and payments be
sent by registered mail, properly insured, with return receipt requested, and
that a sufficient number of days be allowed to ensure delivery to the rights
agent and clearance of payment prior to 5:00 p.m., New York time, on the
expiration date. Because uncertified personal checks may take at least five
business days to clear, rightsholders are strongly urged to pay, or arrange for
payment, by means of certified or cashier's check, money order or wire transfer
of funds.
All questions concerning the timeliness, validity, form and eligibility of
any exercise of rights will be determined by us, and our determinations will be
final and binding. We may waive any defect or irregularity, permit a defect or
irregularity to be corrected or reject the exercise of any right. Rights will
not be deemed to have been received or accepted until all irregularities have
been waived or cured within such time as we determine. Neither Intelli-Check nor
the rights agent will be under any duty to give notification of any defect or
irregularity in connection with the submission of rights certificates or incur
any liability for failure to give such notification.
-12-
Any questions or requests for assistance concerning the method of
exercising rights or requests for additional copies of this prospectus or the
guaranteed notice should be directed to the rights agent whose address and
telephone numbers are set forth on the rights certificate.
NO REVOCATION
Once a rightsholder has exercised rights, such exercise may not be
revoked.
CERTAIN FEDERAL INCOME TAX CONSIDERATIONS
GENERAL
The following is a general discussion of certain U.S. federal income tax
considerations applicable upon the issuance, exercise, redemption and lapse of
the rights issued to the stock rightsholders, option rightsholders, and warrant
rightsholders. This summary is based on provisions of the Internal Revenue Code
of 1986, as amended (the "Code"), regulations of the Treasury Department,
administrative rulings and pronouncements of the Internal Revenue Service and
judicial decisions currently in effect, all of which are subject to change,
possibly with retroactive effect. This discussion does not deal with all aspects
of federal income taxation that may be relevant to particular stock
rightsholders, option rightsholders, and warrant rightsholders in light of their
personal investment circumstances (for example, to persons holding common stock
as part of a conversion transaction or as part of a hedge or hedging
transaction, or as a position in a straddle for tax purposes), nor does it
discuss federal income tax considerations applicable to certain stock
rightsholders, option rightsholders and warrant rightsholders subject to special
treatment under the federal income tax laws (for example, insurance companies,
tax-exempt organizations, financial institutions or broker-dealers, taxpayers
subject to the alternative minimum tax, or non-United States persons).
This discussion only addresses the stock rightsholders, option
rightsholders, and warrant rightsholders who will both hold their respective
interests in Intelli-Check as capital assets and will hold any common stock
received upon exercise of the rights as capital assets (persons who may not be
holding their interests in Intelli-Check as capital assets might include, for
example, securities dealers or traders who do not hold their interests primarily
for investment or who treat their interests as inventory for federal income tax
purposes). In addition, this discussion does not consider the effect of any
foreign, state, local, gift or estate or other tax laws which may apply to a
particular investor. No ruling has been or will be sought from the IRS
concerning the tax issues addressed in this prospectus, and such issues may be
subject to substantial uncertainty resulting from the lack of definitive,
judicial or administrative authority and interpretations. All stock
rightsholders, option rightsholders, and warrant rightsholders are urged to
consult with their own tax advisors regarding the specific tax consequences to
them of the rights dividend, including the effects of federal, state, local,
foreign, and other tax laws.
TAX CONSEQUENCES TO STOCK RIGHTSHOLDERS
Distribution of Rights. Holders of our common stock will not recognize
taxable income for federal income tax purposes upon distribution of the rights.
-13-
Basis And Holding Period. Except as provided in the following sentence,
the basis of the rights received by a shareholder as distribution with respect
to such shareholder's common stock will be zero. If, however, either (1) the
fair market value of the rights on their date of issuance is 15% or more of the
fair market value (on the date of issuance) of the common stock with respect to
which they are received or (2) the shareholder properly elects, in his or her
federal income tax return for the taxable year in which the rights are received,
to allocate part of the basis of such common stock to the rights, then upon
exercise, the shareholder's basis in such common stock will be allocated between
the common stock and the rights in proportion to the fair market values of each
on the date of issuance. The holding period of a shareholder with respect to the
rights received as a distribution on such shareholder's common stock will
include the shareholder's holding period for the common stock with respect to
which the rights were distributed.
Redemption of Rights. If we redeem rights held by a stock rightsholder,
the stock rightsholder will recognize capital gain or loss equal to the
difference between the redemption price and the stock rightsholder's basis, if
any, in those rights.
Lapse of Rights. Stock rightsholders who allow the rights issued to them
to lapse will not recognize any gain or loss, and no adjustment will be made to
the basis of the common stock, if any, they own.
Exercise of Rights. If a stock rightsholder exercises rights, the holder
will recognize taxable income at the time the rights are exercised in an amount
equal to the excess, if any, of the fair market value of the common stock at
that time over the exercise price. That income would be taxed at ordinary income
rates and any gain or loss recognized on the subsequent disposition of the
common stock so acquired would be treated as a capital gain or loss.
TAX CONSEQUENCES TO OPTION RIGHTSHOLDERS
Issuance of Rights. No gain or loss should be recognized by option
rightsholders in connection with the issuance of the rights provided that when
issued the rights do not have a readily ascertainable fair market value within
the meaning of the Treasury Regulations. We believe that rights issued to option
rightsholders should not be treated as having a readily ascertainable fair
market value because the rights are non-transferable and, thus, will not be
actively traded on an established market and the fair market value of the rights
otherwise cannot be measured with reasonable accuracy.
Redemption of Rights. If we redeem rights held by an option rightsholder,
the option rightsholder should recognize ordinary income equal to the redemption
price of those rights.
Lapse of Rights. Option rightsholders who allow rights issued to them to
lapse will not recognize any gain or loss, and no adjustment will be made to the
basis, if any, of any other ownership interest in Intelli-Check owned by the
option rightsholders.
Exercise of Rights. If an option rightsholder exercises their option to
purchase common stock, upon the exercise of the rights that attached to such
common stock, the holder will recognize
-14-
taxable income at the time the rights are exercised in an amount equal to the
excess, if any, of the fair market value of the common stock at that time over
the exercise price. That income would be taxed at ordinary income rates and any
gain or loss recognized on the subsequent disposition of the common stock so
acquired would be treated as a capital gain or loss.
The tax basis of the common stock acquired by an option rightsholder
through the exercise of rights will be equal to the fair market value of the
common stock on the date of exercise and the holding period for that common
stock generally will begin on the day following exercise.
TAX CONSEQUENCES TO WARRANT RIGHTSHOLDERS
Warrants Issued for Services. In the case of warrants issued to warrant
rightsholders in connection with the performance of services, the federal income
tax consequences arising upon the issuance of rights to those warrant
rightsholders and upon the redemption, lapse or exercise of those rights should
be the same as for rights issued to option rightsholders. See " - Tax
Consequences to option rightsholders" above. The following discussion of the
federal income tax consequences arising upon the issuance of rights to warrant
rightsholders and upon the redemption, lapse or exercise of those rights applies
only to warrant rightsholders who did not receive their warrants in connection
with the performance of services.
Issuance of rights. No applicable authority addresses the federal income
tax consequences arising upon the issuance of rights to warrant rightsholders.
Because rights will not be exercisable by warrant rightsholders prior to
exercise of their warrants, substantial uncertainty exists regarding when the
rights will be treated as distributed to warrant rightsholders for federal
income tax purposes. If the rights are treated as distributed upon exercise of a
warrant, we believes the receipt of rights at that time likely will not
constitute a taxable distribution. If, however, the rights are treated as
distributed to a warrant rightsholder before exercise of the warrant, we believe
the issuance of the rights to warrant rightsholders likely will constitute a
taxable distribution. Given the lack of applicable authority regarding these
consequences, warrant rightsholders should consult and rely upon their own tax
advisors as to the specific tax consequences to them relating to the issuance of
rights.
Basis and Holding Period. If the rights dividend is characterized as a
nontaxable distribution made upon exercise of a warrant and either (i) the fair
market value of the rights on the date of distribution is equal to 15% or more
of the fair market value on the date of issuance of the common stock with
respect to which they are received or (ii) the warrant rightsholder elects, in
his or her federal income tax return of the taxable year in which the rights are
received, to allocate part of the tax basis of the common stock to the rights,
then upon exercise or redemption of the rights, the warrant rightsholder's tax
basis in the common stock will be allocated between the common stock and the
rights in proportion to the fair market values of each on the date of the
issuance of the rights. Otherwise, the tax basis of rights received by a warrant
rightsholder as a nontaxable distribution will be zero.
If, however, the distribution of rights to the warrant rightsholders were
treated as a taxable distribution, a warrant rightsholder would have a tax basis
in the rights that such warrant rightsholder received equal to the fair market
value of the rights on the date of distribution of the rights.
-15-
If the rights issued to the warrant rightsholders is treated as a
nontaxable distribution, the holding period of a holder with respect to rights
received as a distribution on the holder's common stock will include the
holder's holding period for the common stock with respect to which the rights
were issued. If, however, the rights issued to the warrant rightsholders were
treated as a taxable distribution, the warrant rightsholders would have a
holding period that begins on the day following the date of distribution of the
rights.
Redemption of Rights. If we redeem rights held by a warrant rightsholder,
the warrant rightsholder will recognize capital gain or loss equal to the
difference between the redemption price and the warrant rightsholder's basis, if
any, in those rights.
Lapse of Rights. If the rights issued to the warrant rightsholders is
treated as a nontaxable distribution, a warrant rightsholder who allows rights
received by him or her to lapse without exercising them will not recognize any
gain or loss and, as the rights were neither exercised nor redeemed, no
adjustment will be made to the tax basis of any interest in the company owned by
the warrant rightsholder. If, however, the rights issued to the warrant
rightsholders were treated as a taxable distribution, a warrant rightsholder who
allowed the rights to lapse would have a capital loss in an amount equal to his
or her tax basis in the rights (as discussed above), and no adjustment would be
made to the tax basis of any interest in the company owned by the warrant
rightsholder.
Exercise of Rights. If a warrant rightsholder exercises their warrant to
purchase common stock, upon the exercise of the rights that attached to such
common stock, the holder will recognize taxable income at the time the rights
are exercised in an amount equal to the excess, if any, of the fair market value
of the common stock at that time over the exercise price. That income would be
taxed at ordinary income rates and any gain or loss recognized on the subsequent
disposition of the common stock so acquired would be treated as a capital gain
or loss.
-16-
LEGAL MATTERS
The validity of the issuance of the common stock offered by this
prospectus has been passed upon for us by Milberg Weiss Bershad Hynes & Lerach
LLP, One Pennsylvania Plaza, New York, New York 10119-1065.
EXPERTS
The financial statements incorporated by reference in this prospectus and
elsewhere in the registration statement have been audited by Arthur Andersen
LLP, independent public accountants, as indicated in their reports with respect
thereto, and are included herein in reliance upon the authority of said firm as
experts in giving said reports.
PRINCIPAL OFFICE
Our principal executive offices are located at 246 Crossways Park West
Woodbury, New York 11797, and our telephone number is (516) 992-1900.
MATERIAL CHANGES
In May 2001, we introduced our C-Link software to the marketplace. C-Link,
when used in conjunction with our ID-Check terminal, has the ability to collect
the information read and stored by the ID-Check terminal and save it to a
computer hard drive for permanent storage. The stored information can then be
searched, analyzed and used to generate demographics, statistics and, where
permitted by law, mailing lists of existing customers.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and special reports, proxy statements and other
information with the SEC. You may read and copy any document we file with the
SEC at the SEC's Public Reference Rooms at Judiciary Plaza, 450 Fifth Street,
N.W., Washington, D.C., 20549. Please call the SEC at 1-800-SEC-0330 for further
information on the public reference rooms. The SEC maintains an Internet site
that contains reports, proxy and information statements, and other information
regarding issuers, such as Intelli-Check, Inc., that file electronically with
the SEC. The address of the site is http://www.sec.gov.
We have filed with the SEC a registration statement on Form S-3 under the
Securities Act of 1933, as amended. This prospectus does not contain all of the
information, exhibits and undertakings set forth in the registration statement,
certain portions of which are omitted as permitted by the rules and regulations
of the SEC. Copies of the registration statement and the exhibits are on file
with the SEC and may be obtained, upon payment of the fee prescribed by the SEC,
or may be examined, without charge, at the offices of the SEC set forth above.
For further information, reference is made to the registration statement and its
exhibits.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents filed by us with the SEC File No. 001-15465 are
incorporated by reference in this prospectus:
o Annual Report on Form 10-KSB for the year ended December 31, 2000.
o Quarterly Report on Form 10-QSB for the quarter ended March 31,
2001.
We incorporate by reference additional documents that we may file with the
SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of
1934, as amended, between the date of this prospectus and the termination of the
offering of securities under this prospectus. These documents include our
periodic reports, such as Annual Reports on Form 10-KSB,
-17-
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as our
proxy statements.
You may obtain any of these incorporated documents from us without charge,
excluding any exhibits to those documents unless the exhibit is specifically
incorporated by reference in such document by requesting them from us in writing
or by telephone at the following address and telephone number:
Intelli-Check, Inc.,
246 Crossways Park West,
Woodbury, New York 11797
(516) 992-1900
-18-
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
SEC registration fee...........................................$ 2,061.41
American Stock Exchange Filing Fee.............................$17,500.00
Legal fees and expenses*.......................................$30,000.00
Accounting fees and expenses*..................................$ 4,000.00
Transfer agent fees*...........................................$ 5,000.00
Printing Fees*.................................................$11,000.00
Miscellaneous*.................................................$18,000.00
----------
Total $87,561.41
----------
*This expense has been estimated for the purpose of filing.
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Intelli-Check's Certificate of Incorporation limits the liability of
directors to the maximum extent permitted by Section 145 of the Delaware General
Corporation Law. Delaware law provides that the directors of a corporation will
not be personally liable to such corporation or its stockholders for monetary
damages for breach of their fiduciary duties as directors, except for liability
(i) for any breach of their duty of loyalty to the corporation or its
stockholders; (ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law; (iii) for unlawful
payments of dividends or unlawful stock repurchases or redemptions as provided
in Section 174 of the Delaware General Corporation Law; or (iv) for any
transaction from which the director derives an improper personal benefit.
Intelli-Check's By-laws provide that the Company shall indemnify its directors
and officers under certain circumstances, including those circumstances in which
indemnification would otherwise be discretionary, and the Company is required to
advance expenses to its officers and directors as incurred in connection with
proceedings against them for which they may be indemnified.
ITEM 16. EXHIBITS.
EXHIBIT NO. DESCRIPTION
----------- -----------
5.1 Opinion of Milberg Weiss Bershad Hynes & Lerach, LLP.*
23.1 Consent of Arthur Andersen LLP.
23.2 Consent of Milberg Weiss Bershad Hynes & Lerach LLP.
(included in Exhibit 5.1 hereto).
24.1 Power of Attorney (included as part of the signature page).*
-19-
99.1 Form of Rights Certificate.*
99.2 Form of Notice of Guaranteed Delivery.*
99.3 Form of Rights Agent Agreement.*
----------
* Previously filed.
ITEM 17. UNDERTAKINGS
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement;
(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represents a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high and of the
estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) if, in
the aggregate, the changes in volume and price represent no more
than 20 percent change in the maximum aggregate offering price set
forth in the "Calculation of Registration Fee" table in the
effective registration statement.
(iii) To include any material information with respect to the plan
of distribution not previously disclosed in the registration
statement or any material change to such information in the
registration statement; provided, however, that paragraphs (a)(1)(i)
and (a)(1)(ii) do not apply if the registration statement is on Form
S-3, Form S-8 or Form F-3, and the information required to be
included in a post-effective amendment by those paragraphs is
contained in periodic reports filed with or furnished to the
Commission by the registrar pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 that are incorporated by reference
in the registration statement.
-20-
(2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.
(3) To remove from the registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.
(b) The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, as amended,
each filing of the registrant's annual report pursuant to Section 13(a) or
15(d) of the Securities Exchange Act of 1934 (and, where applicable, each
filing of an employee benefit plan's annual report pursuant to Section
15(d) of the Securities Exchange Act of 1934) that is incorporated by
reference in the registration statement shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933, as amended, may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that in the
opinion of the Securities and Exchange Commission, such indemnification is
against public policy as expressed in the Securities Act of 1933, as
amended, and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the
Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act of 1933, as amended, and
will be governed by the final adjudication of such issue.
-21-
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, as
amended, the Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements of filing on Form S-3 and authorized this
Amendment No. 1 to the Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of New York, State of New
York, on July 31, 2001.
INTELLI-CHECK, INC.
By: /s/ Frank Mandelbaum
------------------------------------
Frank Mandelbaum
Chairman and Chief Executive Officer
-22-
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Amendment No. 1 to Registration Statement has been signed by the following
persons in the capacities and on the dates indicated below:
Date: July 31, 2001 /s/ Frank Mandelbaum
----------------------------------------------
Frank Mandelbaum
Chairman, Chief Executive Officer and Director
Date: July 31, 2001 /s/ Edwin Winiarz
----------------------------------------------
Edwin Winiarz
Senior Executive Vice President, Treasurer,
Chief Financial Officer, Principal Accounting
Officer and Director
Date: June __, 2001
----------------------------------------------
Evelyn Berezin, Director
Date: July 31, 2001 /s/ Paul Cohen
----------------------------------------------
Paul Cohen, Director
Date: July 31, 2001 /s/ Howard Davis
----------------------------------------------
Howard Davis, Director
Date: July 31, 2001 /s/ Jeffrey Levy
----------------------------------------------
Jeffrey Levy, Director
Date: July 31, 2001 /s/ Charles McQuinn
----------------------------------------------
Charles McQuinn, Director
*By: /s/ Frank Mandelbaum
---------------------------
Frank Mandelbaum
Attorney-in-Fact
-23-
Exhibit Index
EXHIBIT NO. DESCRIPTION
----------- -----------
5.1 Opinion of Milberg Weiss Bershad Hynes & Lerach, LLP.*
23.1 Consent of Arthur Andersen LLP.
23.2 Consent of Milberg Weiss Bershad Hynes & Lerach, LLP.
(included in Exhibit 5.1 hereto).
24.1 Power of Attorney (included as part of the signature page).*
99.1 Form of Rights Certificate.*
99.2 Form of Notice of Guaranteed Delivery.*
99.3 Form of Rights Agent Agreement.*
----------
* Previously filed